• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevention of diabetes and left ventricular hypertrophy with AT1 receptor blockade for hypertension.

作者信息

Carey Robert M

出版信息

Curr Hypertens Rep. 2008 Apr;10(2):91-2. doi: 10.1007/s11906-008-0018-x.

DOI:10.1007/s11906-008-0018-x
PMID:18474173
Abstract
摘要

相似文献

1
Prevention of diabetes and left ventricular hypertrophy with AT1 receptor blockade for hypertension.使用AT1受体阻滞剂治疗高血压以预防糖尿病和左心室肥厚。
Curr Hypertens Rep. 2008 Apr;10(2):91-2. doi: 10.1007/s11906-008-0018-x.
2
Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.血管紧张素AT1受体抑制。对升主动脉缩窄所致压力超负荷肥大大鼠肥厚性重塑和ACE表达的影响。
Circulation. 1997 Mar 18;95(6):1592-600. doi: 10.1161/01.cir.95.6.1592.
3
Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.犬左心室肥厚发展过程中血管紧张素II 1型受体阻断：对心室和心肌细胞功能的影响
J Cardiovasc Pharmacol. 1997 Nov;30(5):623-31. doi: 10.1097/00005344-199711000-00013.
4
Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.2型糖尿病伴左心室扩张患者中抗β1受体和抗AT1受体自身抗体
Cardiology. 2014;129(3):191-6. doi: 10.1159/000365782. Epub 2014 Oct 11.
5
Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.肾移植受者中通过AT1受体阻断使左心室肥厚消退
Am J Hypertens. 2000 Dec;13(12):1295-300. doi: 10.1016/s0895-7061(00)01213-9.
6
Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.激肽对大鼠心肌梗死后存活心肌中心肌细胞肥大和间质胶原基质的不同作用。
Circulation. 1997 Apr 1;95(7):1910-7. doi: 10.1161/01.cir.95.7.1910.
7
Regression of left ventricular hypertrophy in human hypertension with irbesartan.厄贝沙坦治疗人类高血压左心室肥厚的消退情况
J Hypertens. 2001 Jun;19(6):1167-76. doi: 10.1097/00004872-200106000-00023.
8
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.血管紧张素II 1型受体拮抗剂在老年高血压患者中的作用。
Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004.
9
Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.血管紧张素转换酶抑制和血管紧张素II AT1受体拮抗对左心室肥厚心脏参数的影响。
Am J Cardiol. 1997 Aug 4;80(3A):110A-117A. doi: 10.1016/s0002-9149(97)00465-7.
10
Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.肾素-血管紧张素系统和内皮素系统在高血压性心脏病舒张性心力衰竭发生中的作用。
Cardiovasc Res. 2000 Aug;47(2):274-83. doi: 10.1016/s0008-6363(00)00101-2.

本文引用的文献

1
Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone?左心室肥厚逆转与糖尿病预防：一箭双雕？
Hypertension. 2007 Nov;50(5):851-3. doi: 10.1161/HYPERTENSIONAHA.107.099747. Epub 2007 Sep 24.
2
Reducing diabetes incidence through the inhibition of the renin-angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?
J Cardiovasc Med (Hagerstown). 2007 Jul;8(7):473-82. doi: 10.2459/01.JCM.0000278445.04613.27.
3
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.抗高血压药物临床试验中的新发糖尿病：一项网状Meta分析。
Lancet. 2007 Jan 20;369(9557):201-7. doi: 10.1016/S0140-6736(07)60108-1.
4
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.糖尿病对心电图左心室肥厚消退及降压治疗期间预后预测的影响：氯沙坦干预降低高血压终点事件（LIFE）研究
Circulation. 2006 Mar 28;113(12):1588-96. doi: 10.1161/CIRCULATIONAHA.105.574822. Epub 2006 Mar 13.
5
Putting LIFE into hypertension.为高血压注入生命活力。
Curr Hypertens Rep. 2002 Aug;4(4):275-7. doi: 10.1007/s11906-996-0004-0.
6
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.氯沙坦干预降低高血压终点事件研究（LIFE）中糖尿病患者的心血管发病率和死亡率：一项与阿替洛尔对比的随机试验
Lancet. 2002 Mar 23;359(9311):1004-10. doi: 10.1016/S0140-6736(02)08090-X.
7
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.氯沙坦干预降低高血压终点事件研究（LIFE）中的心血管发病率和死亡率：一项与阿替洛尔对比的随机试验。
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
8
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.高血压及抗高血压治疗作为2型糖尿病的危险因素。社区动脉粥样硬化风险研究。
N Engl J Med. 2000 Mar 30;342(13):905-12. doi: 10.1056/NEJM200003303421301.
9
Microvascular function relates to insulin sensitivity and blood pressure in normal subjects.
Circulation. 1999 Feb 23;99(7):896-902. doi: 10.1161/01.cir.99.7.896.
10
The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension.
Blood Press. 1994 May;3(3):185-8. doi: 10.3109/08037059409102250.